LAVA Therapeutics N.V.
Biotechnology Research
United States
36 employees
- Employees
- 36
- Contacts
- 3
- Emails
- 3
- Phones
- 2
LAVA Therapeutics N.V. Overview
- Headquarters
- United States
- Phone Number
- Available in AeroLeads
- Website
- www.lavatherapeutics.com
- Industry
- Biotechnology Research
- Employees
- 36
- Founded
- 2016
- Funding
- 83.0M
- Company Email
- Available in AeroLeads
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About LAVA Therapeutics N.V.
At LAVA, we are focused on applying our expertise in gamma-delta T-cell engagers (TCEs) to transform cancer therapy. We refer to our compounds as gamma-delta bispecific T-cell engagers, or gamma-delta bsTCEs. Our platform generates therapeutics that specifically activate a unique and relatively abundant effector gamma-delta T-cell subset called Vγ9Vδ2 (Vgamma9-Vdelta2) T-cells that have the ability to trigger activity of immune cells of both the innate and adaptive immune system. Our gamma-delta bsTCEs have demonstrated superior efficacy and safety profiles compared to other bsTCE approaches in preclinical studies and show preferential activity against tumor cells thereby potentially limiting toxicity in healthy tissue. To date, we are the only company developing bispecific gamma-delta T-cell engaging antibodies for the treatment of cancer. We are building a pipeline of gamma-delta bsTCEs that have applications in both solid and hematologic malignancies. Our lead program, LAVA-051, targets the tumor specific antigen CD1d, which can be overexpressed in multiple myeloma, chronic lymphocytic leukemia (CLL), and acute myeloid leukemia (AML), among other tumor types. LAVA-051 will enter a Phase I/IIa study in 1Q21.
LAVA Therapeutics N.V. Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
- Phone contacts
- 2
- 50.0% coverage
LAVA Therapeutics N.V. Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Peter Ros | Vice President Finance & Operations - Finance & Accounting Professional - Non-executive Board Member - Associate at Imra Netwerk | Netherlands |
Email
|
| Fred M. Powell | Pharmaceutical Executive | Jamison, Pennsylvania, United States |
Email
Phone
|
| Stephen Hurly | CEO, President, Director at Lava Therapeutics | Philadelphia, Pennsylvania, United States |
Email
Phone
|
| Amy Garabedian | Biotech General Counsel - Trusted Legal Partner for Growth-stage & Emerging Biotechs - Transactions - Ip - Strategic Guidance - Governance |
View
|
Employees by Management Level
Individual contributor
5 profiles
Senior / Lead
4 profiles
Executive
3 profiles
Manager
1 profile
Department Contact Coverage
| Department | Contacts | Phone | |
|---|---|---|---|
| General | 8 | 8 | 0 |
Compare Similar Companies to LAVA Therapeutics N.V.
Genmab
Biotechnology Research
uniQure
Biotechnology Research
Merus N.V.
Biotechnology Research
ProQR Therapeutics
Biotechnology Research
LUMICKS
Biotechnology Research
Batavia Biosciences
Biotechnology
VectorY
Biotechnology Research
Leyden Labs
Biotechnology Research
Neogene Therapeutics
Biotechnology Research
Scenic Biotech
Biotechnology Research